Georges Gemayel's Net Worth

$2.16 Million

Estimate Recalculated Nov 11, 2024 02:53AM EST

Who is Georges Gemayel?

Georges Gemayel has an estimated net worth of $2.16 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Altus Pharmaceuticals Inc., SUPERNUS PHARMACEUTICALS, INC., Disc Medicine, Inc., Dimension Therapeutics, Inc., NPS PHARMACEUTICALS INC, Raptor Pharmaceutical Corp, ADOLOR CORP, and MOMENTA PHARMACEUTICALS INC.

SEC CIK

Georges Gemayel's CIK is 0001256088

Past Insider Trading and Trends

2011 was Georges Gemayel's most active year for acquiring shares with 9 total transactions. Georges Gemayel's most active month to acquire stocks was the month of April. 2020 was Georges Gemayel's most active year for disposing of shares, totalling 10 transactions. Georges Gemayel's most active month to dispose stocks was the month of September. 2007 saw Georges Gemayel paying a total of $1,839,585.30 for 121,096 shares, this is the most they've acquired in one year. In 2007 Georges Gemayel cashed out on 77,277 shares for a total of $2,850,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GENZYME CORP No price found

Executive Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$61.20
-$1,110,375.00
9.04K
Oct 30
Form 4
+34.37%
2.28K
$43.90
$99,960.30
8.9K
May 31
Form 4
—
0
—
—
0
May 24
Form 4/A
+59.64%
3K
$56.47
$169,410.00
8.03K
May 11
Form 4
+28.36%
2.28K
$43.90
$99,960.30
10.31K
May 30
Form 4
—
0
—
—
0
May 25
Form 4
+59.64%
3K
$56.47
$169,410.00
8.03K
May 11
Form 4
+68.98%
2.28K
$56.26
-$82,893.70
5.58K
Jul 15
Form 4
—
0
—
—
0
May 26
Form 4
+271.07%
2.28K
$55.34
-$352,789.70
3.12K
May 12
Form 4
—
0
—
—
0
May 27
Form 3
—
0
—
—
0
No matching records found

Altus Pharmaceuticals Inc. No price found

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 19
Form 4
—
0
—
—
0
Jan 27
Form 4
—
0
—
—
0
Jun 2
Form 3
—
0
—
—
0
No matching records found

SUPERNUS PHARMACEUTICALS, INC. (SUPN) Snapshot price: $33.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$24.04
-$357,599.08
13.31K
Nov 7
Form 4
-22.59%
-3.89K
$21.40
-$320,448.38
13.31K
Sep 13
Form 4
+29.19%
3.89K
—
—
17.2K
Feb 23
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Feb 23
Form 4
+41.15%
3.88K
—
—
13.31K
Feb 22
Form 4
—
0
—
—
0
Feb 22
Form 4
+81.02%
4.22K
—
—
9.43K
Feb 19
Form 4
—
0
—
—
0
Feb 19
Form 4
∞
5.21K
$23.99
$125,011.89
5.21K
Feb 21
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Feb 24
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Mar 23
Form 3
—
0
—
—
0
No matching records found

Disc Medicine, Inc. (IRON) Snapshot price: $50.35

Executive Chair the Board

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Dec 29
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Nov 15
Form 4
—
0
—
—
0
Apr 29
Form 3
—
0
—
—
0
No matching records found

Dimension Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 7
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 19
Form 3
—
0
—
—
0
No matching records found